Thermo Fisher announced it has completed its acquisition of Life Technologies (formerly Microprobe)
On Feb. 3, 2014, Thermo Fisher announced it had completed its acquisition of Life Technologies for $76.13 in…
On Feb. 3, 2014, Thermo Fisher announced it had completed its acquisition of Life Technologies for $76.13 in…
On Jan. 13, 2014, Gary K. Michelson, a retired orthopaedic spinal surgeon whose groundbreaking work generated more than…
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
On Sept. 9, 2013 Genentech announced that Richard Scheller, Ph.D., Executive VP, Research and Early Development, was a…
On Jul. 23, 2013, Matrical Bioscience announced it has had been acquired by Chelmsford, Massachusetts-based Brooks Automation for…
On Jun. 20, 2013 – Syntrix Biosystems announced a federal court in Tacoma, had granted the Auburn-based company…
On Apr. 3, 2013, scientists announced they had decoded the genome of the western painted turtle, one of…
On Mar. 27, 2013, researchers at the University of British Columbia and Canada’s Michael Smith Genome Sciences Centre…
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had approved Genentech’s licensed ado-trastuzumab…
On Feb. 7, 2023, scientists from the National Oceanic and Atmospheric Administration (NOAA) Fisheries’ tissue library announced they…
On Dec. 12, 2012, deCODE genetics announced an agreement whereby Amgen acquired deCODE Genetics, a global leader in…
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
In 2012, Ryan Phelan and Stewart Brand founded the Revive & Restore project within The Long Now Foundation,…
On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
In 2012, CALIBR, the California Institute for Biomedical Research (Calibr), was launched as a nonprofit translational research institute…
On Aug. 17, 2011, Genentech announced that Elborafï¾® (vemurafenib) was approved by the FDA for the treatment of…
On Aug. 17, 2011, Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks. When…
On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…
On Mar. 28, 2011, the Priestley Medal was awarded to Ahmed H. Zewail by the American Chemical Society…
On Mar. 23, 2011, J. Craig Venter Institute researchers announced Single Virus Genomics, enabling the isolation and complete…
On Feb. 9, 2011, the University of California, San Francisco (UCSF) celebrated the official opening of the Ray…
On Feb. 9, 2011, Stanford researchers used skin cells from patients with a severe genetic heart defect to…